Genetic Engineering and Biotechnology News reports on early ADMET use
NEW ROCHELLE, NY, May 5, 2008Biotech and pharma companies are increasingly utilizing novel technologies to assess the druggability of test compounds early in the development cycle to avoid costly late clinical-stage attrition, according to Genetic Engineering and Biotechnology News (GEN) ( http://...Ono Enters into a New Fragment-Based Drug Discovery Agreement with Evotec
...eening in combination with its high-quality fragment libraries. In the collaboration it is combined with Evotec's expertise in medicinal chemistry and admet to further characterize active compounds identified and optimize their potency and selectivity to generate molecules for subsequent progression into c...Genetic Engineering and Biotechnology News (GEN) Reports on Early ADMET Use
NEW ROCHELLE, N.Y., May 5 /PRNewswire/ -- Biotech and pharma companies are increasingly utilizing novel technologies to assess the druggability of test compounds early in the development cycle to avoid costly late clinical-stage attrition, according to Genetic Engineering and Biotechnology New...Palkion Selects Novel Oral Development Candidate for the Treatment of Anemia
...d proprietary platform technologies for structural biology, structure-based novel scaffold/lead design, lead optimization and candidate selection with admet capability. CrystalGenomics is headquartered in Seoul, Korea and its subsidiary, CG Pharmaceuticals Inc. is located in Emeryville, CA for US and EU cl...Celsis Outlines the Top Five Advantages of Cryo-plateable Hepatocytes
... to results , enabling more productive and cost-effective research. Celsis IVT's cryo-plateable hepatocytes (the world's largest inventory) and other admet research tools are available worldwide. Visit www.celsis.com/ivt for more information. About Celsis International plc Celsis Internationa...Evotec Expands Collaboration With InterMune
...ry know-how. In addition, they will utilize their expertise and technologies in computational chemistry, protein production, X-Ray crystallography and admet to further characterize active compounds and optimize their potency and selectivity to generate lead molecules for subsequent progression into clinica...BioReliance Launches Next-Generation Genotoxicity Screening Service
...evelopment. Gentronix's first product release, GreenScreen, successfully combines expertise in molecular biology and analytical science to address the admet bottleneck in lead candidate selection, focusing specifically on genotoxicity screening. GreenScreen products are for use in genetic toxicity screenin...